A role for NF-κB activity in skin hyperplasia and the development of keratoacanthomata in mice

PLoS ONE

Volumn 8, Issue 8, 2013, Pages

  Poligone, Brian ^a   Hayden, Matthew S ^b   Chen, Luojing ^a   Pentland, Alice P ^a   Jimi, Eijiro ^c   Ghosh, Sankar ^b  

^a UNIVERSITY OF ROCHESTER SCHOOL OF MEDICINE AND DENTISTRY   (United States)

^b Columbia University ^*  (United States)

^c KYUSHU DENTAL COLLEGE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKERATIN 10; CYTOKERATIN 13; DIMETHYLBENZ[A]ANTHRACENE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; PHORBOL ESTER; PROTEIN P53; SYNAPTOTAGMIN I; TUMOR NECROSIS FACTOR RECEPTOR 1; PHORBOL 13 ACETATE 12 MYRISTATE; RELA PROTEIN, MOUSE; TNFRSF1A PROTEIN, MOUSE; TRANSCRIPTION FACTOR RELA;

ALLELE; AMINO ACID SUBSTITUTION; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL PROLIFERATION; CELL TRANSFORMATION; CHEMICAL CARCINOGENESIS; CLINICAL FEATURE; CODON; CONTROLLED STUDY; EPIDERMIS HYPERPLASIA; GENE MUTATION; GENE TARGETING; HETEROZYGOTE; HISTOLOGY; HOMOZYGOTE; KERATINOCYTE; KERATOACANTHOMATA; MOUSE; NONHUMAN; ONCOGENE H RAS; PAPILLOMA; PROTEIN EXPRESSION; PROTEIN FUNCTION; SKIN CANCER; SKIN CARCINOGENESIS; SKIN EXAMINATION; TUMOR SUPPRESSOR GENE; WILD TYPE MOUSE; 129 MOUSE; ANIMAL; C57BL MOUSE; CHEMICALLY INDUCED; DEFICIENCY; GENETICS; HYPERPLASIA; KERATOACANTHOMA; KNOCKOUT MOUSE; METABOLISM; PATHOLOGY; SIGNAL TRANSDUCTION; SKIN; SKIN TUMOR;

MUS;

AMINO ACID SUBSTITUTION; ANIMALS; CELL PROLIFERATION; HYPERPLASIA; KERATOACANTHOMA; MICE; MICE, 129 STRAIN; MICE, INBRED C57BL; MICE, KNOCKOUT; PAPILLOMA; RECEPTORS, TUMOR NECROSIS FACTOR, TYPE I; SIGNAL TRANSDUCTION; SKIN; SKIN NEOPLASMS; TETRADECANOYLPHORBOL ACETATE; TRANSCRIPTION FACTOR RELA;

EID: 84918831301     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0071887     Document Type: Article

References (39)

1. Brash DE (2006) Roles of the transcription factor p53 in keratinocyte carcinomas. Br J Dermatol 154 Suppl 1: 8-10. doi:10.1111/j. 1365-2133.2006.07230.x. PubMed: 16712710.
2. Li G, Tron V, Ho V (1998) Induction of Squamous Cell Carcinoma in p53-Deficient Mice after Ultraviolet Irradiation. J Invest Dermatol 110: 72-75. doi:10.1046/j.1523-1747.1998.00090.x. PubMed: 9424091.
3. van der Schroeff JG, Evers LM, Boot AJ, Bos JL (1990) Ras oncogene mutations in basal cell carcinomas and squamous cell carcinomas of human skin. J Invest Dermatol 94: 423-425. doi: 10.1111/1523-1747.ep12874504. PubMed: 2179417.
4. Dajee M, Lazarov M, Zhang JY, Cai T, Green CL et al. (2003) NF-κB blockade and oncogenic Ras trigger invasive human epidermal neoplasia. Nature 421: 639-643. doi:10.1038/nature01283. PubMed: 12571598.
5. Loercher A, Lee TL, Ricker JL, Howard A, Geoghegen J et al. (2004) Nuclear Factor-κB is an Important Modulator of the Altered Gene Expression Profile and Malignant Phenotype in Squamous Cell Carcinoma. Cancer Res 64: 6511-6523. doi: 10.1158/0008-5472.CAN-04-0852. PubMed: 15374962.
6. van Hogerlinden M, Rozell BL, Ahrlund-Richter L, Toftgård R (1999) Squamous cell carcinomas and increased apoptosis in skin with inhibited Rel/nuclear factor-kappaB signaling. Cancer Res 59: 3299-3303. PubMed: 10416581.
7. de Gruijl FR, van der Leun JC (1991) Development of skin tumors in hairless mice after discontinuation of ultraviolet irradiation. Cancer Res 51: 979-984. PubMed: 1988142.
8. Roewert-Huber J, Stockfleth E, Kerl H (2007) Pathology and pathobiology of actinic (solar) keratosis-an update. Br J Dermatol 157 Suppl 2: 18-20. doi:10.1111/j.1365-2133.2007.08267.x. PubMed: 18067626.
9. Iden S, van Riel Wilhelmina E, Schäfer R, Song J-Y, Hirose T et al. (2012) Tumor Type-Dependent Function of the Par3 Polarity Protein in Skin Tumorigenesis. Cancer Cell 22: 389-403. doi:10.1016/j.ccr. 2012.08.004. PubMed: 22975380.
10. Rogers LM, Riordan JD, Swick BL, Meyerholz DK, Dupuy AJ (2013) Ectopic Expression of Zmiz1 Induces Cutaneous Squamous Cell Malignancies in a Mouse Model of Cancer. J Invest Dermatol.
11. Hayden MS, Ghosh S (2008) Shared principles in NF-kappaB signaling. Cell 132: 344-362. doi:10.1016/j.cell.2008.01.020. PubMed: 18267068.
12. Sur I, Ulvmar M, Toftgård R (2008) The two-faced NF-kappaB in the skin. Int Rev Immunol 27: 205-223. doi:10.1080/08830180802130319. PubMed: 18574737.
13. Klement JF, Rice NR, Car BD, Abbondanzo SJ, Powers GD et al. (1996) IkappaBalpha deficiency results in a sustained NF-kappaB response and severe widespread dermatitis in mice. Mol Cell Biol 16: 2341-2349. PubMed: 8628301.
14. Ren Q, Kari C, Quadros MR, Burd R, McCue P et al. (2006) Malignant transformation of immortalized HaCaT keratinocytes through deregulated nuclear factor kappa B signaling. Cancer Res 66: 5209-5215. doi:10.1158/0008-5472.CAN-05-4158. PubMed: 16707445.
15. Kim H, Casta A, Tang X, Luke CT, Kim AL et al. (2012) Loss of Hairless Confers Susceptibility to UVB-Induced Tumorigenesis via Disruption of NF-kappaB Signaling. PLOS ONE 7: e39691. doi: 10.1371/journal.pone.0039691. PubMed: 22761871.
16. Bassères DS, Baldwin AS (2006) Nuclear factor-kappaB and inhibitor of kappaB kinase pathways in oncogenic initiation and progression. Oncogene 25: 6817-6830. doi:10.1038/sj.onc.1209942. PubMed: 17072330.
17. Dong J, Jimi E, Zeiss C, Hayden MS, Ghosh S (2010) Constitutively active NF-kappaB triggers systemic TNFalpha-dependent inflammation and localized TNFalpha-independent inflammatory disease. Genes Dev 24: 1709-1717. doi:10.1101/gad.1958410. PubMed: 20713516.
18. Zhong H, SuYang H, Erdjument-Bromage H, Tempst P, Ghosh S (1997) The transcriptional activity of NF-kappaB is regulated by the IkappaB-associated PKAc subunit through a cyclic AMP-independent mechanism. Cell 89: 413-424. doi:10.1016/S0092-8674(00)80222-6. PubMed: 9150141.
19. Zhong H, Voll RE, Ghosh S (1998) Phosphorylation of NF-kappaB p65 by PKA stimulates transcriptional activity by promoting a novel bivalent interaction with the coactivator CBP/p300. Mol Cell 1: 661-671. doi: 10.1016/S1097-2765(00)80066-0. PubMed: 9660950.
20. Zhong H, May MJ, Jimi E, Ghosh S (2002) The phosphorylation status of nuclear NF-kappaB determines its association with CBP/p300 or HDAC-1. Mol Cell 9: 625-636. doi:10.1016/S1097-2765(02)00477-X. PubMed: 11931769.
21. Dong J, Jimi E, Zhong H, Hayden MS, Ghosh S (2008) Repression of gene expression by unphosphorylated NF-kappaB p65 through epigenetic mechanisms. Genes Dev 22: 1159-1173. doi:10.1101/gad. 1657408. PubMed: 18408078.
22. Yao D, Alexander CL, Quinn JA, Porter MJ, Wu H et al. (2006) PTEN loss promotes rasHa-mediated papillomatogenesis via dual up-regulation of AKT activity and cell cycle deregulation but malignant conversion proceeds via PTEN-associated pathways. Cancer Res 66: 1302-1312. doi:10.1158/0008-5472.CAN-05-2341. PubMed: 16452183.
23. Romano RA, Smalley K, Magraw C, Serna VA, Kurita T et al. (2012) DeltaNp63 knockout mice reveal its indispensable role as a master regulator of epithelial development and differentiation. Development 139: 772-782. doi:10.1242/dev.071191. PubMed: 22274697.
24. Kucharczak J, Simmons MJ, Fan Y, Gelinas C (2003) To be, or not to be: NF-kappaB is the answer-role of Rel/NF-kappaB in the regulation of apoptosis. Oncogene 22: 8961-8982. doi:10.1038/sj.onc.1207230. PubMed: 14663476.
25. Abel EL, Angel JM, Kiguchi K, DiGiovanni J (2009) Multi-stage chemical carcinogenesis in mouse skin: fundamentals and applications. Nat Protoc 4: 1350-1362. doi:10.1038/nprot.2009.120. PubMed: 19713956.
26. Goel G, Makkar HPS, Francis G, Becker K (2007) Phorbol Esters: Structure, Biological Activity, and Toxicity in Animals. Int J Toxicol 26: 279-288. doi:10.1080/10915810701464641. PubMed: 17661218.
27. Karin M Volumes 2006 (personal communication).
28. Perez P, Lira SA, Bravo R (1995) Overexpression of RelA in transgenic mouse thymocytes: specific increase in levels of the inhibitor protein I kappa B alpha. Mol Cell Biol 15: 3523-3530. PubMed: 7791759.
29. Wullaert A, Bonnet MC, Pasparakis M (2011) NF-κB in the regulation of epithelial homeostasis and inflammation. Cell Res 21: 146-158. doi: 10.1038/cr.2010.175. PubMed: 21151201.
30. Page A, Cascallana JL, Casanova ML, Navarro M, Alameda JP et al. (2011) IKKbeta overexpression leads to pathologic lesions in stratified epithelia and exocrine glands and to tumoral transformation of oral epithelia. Mol Cancer Res MCR 9: 1329-1338. doi: 10.1158/1541-7786.MCR-11-0168.
31. Lind MH, Rozell B, Wallin RPA, van Hogerlinden M, Ljunggren H-G et al. (2004) Tumor necrosis factor receptor 1-mediated signaling is required for skin cancer development induced by NF-κB inhibition. Proc Natl Acad Sci USA 101: 4972-4977. doi:10.1073/pnas.0307106101. PubMed: 15044707.
32. Pasparakis M, Courtois G, Hafner M, Schmidt-Supprian M, Nenci A et al. (2002) TNF-mediated inflammatory skin disease in mice with epidermis-specific deletion of IKK2. Nature 417: 861-866. doi:10.1038/nature00820. PubMed: 12075355.
33. Suganuma M, Okabe S, Marino MW, Sakai A, Sueoka E et al. (1999) Essential role of tumor necrosis factor alpha (TNF-alpha) in tumor promotion as revealed by TNF-alpha-deficient mice. Cancer Res 59: 4516-4518. PubMed: 10493498.
34. van Hogerlinden M, Rozell BL, Toftgård R, Sundberg JP (2004) Characterization of the progressive skin disease and inflammatory cell infiltrate in mice with inhibited NF-kappaB signaling. J Invest Dermatol 123: 101-108. doi:10.1111/j.0022-202X.2004.22706.x. PubMed: 15191549.
35. van Hogerlinden M, Auer G, Toftgård R (2002) Inhibition of Rel/Nuclear Factor-kappaB signaling in skin results in defective DNA damage-induced cell cycle arrest and Ha-ras-and p53-independent tumor development. Oncogene 21: 4969-4977. doi:10.1038/sj.onc.1205620. PubMed: 12118375.
36. Page A, Navarro M, Garín M, Pérez P, Casanova ML et al. (2010) IKKbeta leads to an inflammatory skin disease resembling interface dermatitis. J Invest Dermatol 130: 1598-1610. doi:10.1038/jid.2010.28. PubMed: 20200541.
37. Page A, Cascallana JL, Casanova ML, Navarro M, Alameda JP et al. (2011) IKK{beta} overexpression leads to pathological lesions in stratified epithelia and exocrine glands and to tumoral transformation of oral epithelia. Mol Cancer Res 5: 5.
38. Ko CJ (2010) Keratoacanthoma: facts and controversies. Clin Dermatol 28: 254-261. doi:10.1016/j.clindermatol.2009.06.010. PubMed: 20541676.
39. Clausen OP, Aass HC, Beigi M, Purdie KJ, Proby CM et al. (2006) Are keratoacanthomas variants of squamous cell carcinomas? A comparison of chromosomal aberrations by comparative genomic hybridization. J Invest Dermatol 126: 2308-2315. doi:10.1038/sj.jid. 5700375. PubMed: 16728973.